QH101 Cell Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for QH101 Cell Therapy, covering 2025-08-20 to 2025-08-20. Get the full timeline:
Most recent: Clinical Trial Update: QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS) [Phase 1]